Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHAD C CHERINGTON

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1285952390
CMS profile
1297720
Location
MESA, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$6,317.83

238 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,938.63 227
Consulting Fee $1,760.00 1
Education $419.20 9
Honoraria $200.00 1

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
SERVIER PHARMACEUTICALS LLC $1,781.22 2
Janssen Biotech, Inc. $387.94 19
Celgene Corporation $287.63 18
E.R. Squibb & Sons, L.L.C. $280.66 23
Astellas Pharma US Inc $262.99 6
Novartis Pharmaceuticals Corporation $226.84 15
Merck Sharp & Dohme LLC $203.27 11
Novocure GmbH $200.00 1
PFIZER INC. $189.61 13
GENZYME CORPORATION $181.23 9
Daiichi Sankyo Inc. $147.46 7
Pharmacyclics LLC, an AbbVie Company $142.82 8
EISAI INC. $141.81 7
Genentech USA, Inc. $133.71 8
Seagen Inc. $133.02 8
Gilead Sciences, Inc. $125.69 7
Exelixis Inc. $123.70 7
Intuitive Surgical, Inc. $92.59 1
AstraZeneca Pharmaceuticals LP $91.24 5
Takeda Pharmaceuticals U.S.A., Inc. $78.99 3
Karyopharm Therapeutics Inc. $78.16 3
Amgen Inc. $68.79 5
Global Blood Therapeutics, Inc. $63.21 4
AVEO Pharmaceuticals, Inc. $59.09 3
Regeneron Healthcare Solutions, Inc. $58.52 3
Bayer HealthCare Pharmaceuticals Inc. $56.87 3
Blueprint Medicines Corporation $52.90 3
Kite Pharma, Inc. $52.85 3
Ipsen Biopharmaceuticals, Inc $52.83 3
Myovant Sciences Inc. $51.69 3
TerSera Therapeutics LLC $48.35 2
ABBVIE INC. $42.73 2
ARRAY BIOPHARMA INC $40.43 3
PUMA BIOTECHNOLOGY, INC. $39.64 2
JAZZ PHARMACEUTICALS INC. $38.29 2
Incyte Corporation $38.20 2
G1 Therapeutics, Inc. $38.11 2
GlaxoSmithKline, LLC. $29.87 1
MAYNE PHARMA INC. $25.15 1
Sun Pharmaceutical Industries Inc. $22.12 1
EMD Serono, Inc. $20.95 1
Sobi, Inc $20.05 1
Chiesi USA, Inc. $19.25 1
Organon LLC $16.48 1
Rigel Pharmaceuticals, Inc. $16.04 1
MorphoSys, US Inc. $15.64 1
Alexion Pharmaceuticals, Inc. $14.26 1
Adaptive Biotechnologies Corporation $12.77 1
Lilly USA, LLC $12.17 1

Page 4 of 5; records 151–200 of 238 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHAD C CHERINGTON

NPI 1285952390 · CMS profile ID 1297720

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

MESA, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 5; records 151–200 of 238 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1285952390?year=2022&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHAD C CHERINGTON, NPI 1285952390, CMS profile ID 1297720. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 238 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1285952390?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHAD C CHERINGTON, NPI 1285952390, CMS profile ID 1297720. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 238 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1285952390?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHAD C CHERINGTON, NPI 1285952390, CMS profile ID 1297720, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 5; records 151–200 of 238 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1285952390?year=2022&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

238 matching records · $6,317.83 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 238 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 238.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $21.0404/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939016641 CMS
E.R. Squibb & Sons, L.L.C. $9.8904/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932957199 CMS
Novartis Pharmaceuticals Corporation $10.1604/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893568307 CMS
Janssen Biotech, Inc. $16.5204/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885505281 CMS
EISAI INC. $23.2804/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908025049 CMS
EISAI INC. $22.4504/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908025053 CMS
Merck Sharp & Dohme LLC $24.8404/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944785421 CMS
AstraZeneca Pharmaceuticals LP $14.4004/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915551297 CMS
Novartis Pharmaceuticals Corporation $14.7204/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893568303 CMS
Exelixis Inc. $18.1504/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932461849 CMS
Adaptive Biotechnologies Corporation $12.7704/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951435567 CMS
Daiichi Sankyo Inc. $22.6503/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930821937 CMS
E.R. Squibb & Sons, L.L.C. $9.7703/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932957195 CMS
Janssen Biotech, Inc. $19.5303/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885505285 CMS
PUMA BIOTECHNOLOGY, INC. $22.4303/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942289979 CMS
Celgene Corporation $11.3203/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932957299 CMS
Gilead Sciences, Inc. $20.2803/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929592967 CMS
Pharmacyclics LLC, an AbbVie Company $13.8603/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890338071 CMS
Myovant Sciences Inc. $18.1603/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941186263 CMS
EISAI INC. $14.8603/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908025061 CMS
Lilly USA, LLC $12.1703/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917939209 CMS
GENZYME CORPORATION $23.9603/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939016615 CMS
AVEO Pharmaceuticals, Inc. $22.3103/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950102583 CMS
GENZYME CORPORATION $17.4803/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939016617 CMS
Amgen Inc. $16.0003/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939905995 CMS
Novartis Pharmaceuticals Corporation $12.6203/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893568301 CMS
Janssen Biotech, Inc. $2.9803/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885505295 CMS
PFIZER INC. $13.2803/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949078467 CMS
PFIZER INC. $13.5603/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949089157 CMS
Pharmacyclics LLC, an AbbVie Company $21.6803/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890338069 CMS
E.R. Squibb & Sons, L.L.C. $14.0803/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932957047 CMS
Astellas Pharma US Inc $79.9902/28/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940131973 CMS
Astellas Pharma US Inc $99.9502/28/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940131979 CMS
PFIZER INC. $19.1502/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949074655 CMS
Celgene Corporation $7.7602/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932957045 CMS
Alexion Pharmaceuticals, Inc. $14.2602/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914836351 CMS
E.R. Squibb & Sons, L.L.C. $9.9302/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932957039 CMS
Merck Sharp & Dohme LLC $14.5502/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944786517 CMS
Karyopharm Therapeutics Inc. $24.0102/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946513955 CMS
AstraZeneca Pharmaceuticals LP $19.4202/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915520209 CMS
Astellas Pharma US Inc $22.0902/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940127833 CMS
Janssen Biotech, Inc. $2.6202/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885505257 CMS
Celgene Corporation $15.9702/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932957043 CMS
Genentech USA, Inc. $12.1902/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950797797 CMS
Astellas Pharma US Inc $19.0902/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940126021 CMS
Novartis Pharmaceuticals Corporation $17.4202/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893568295 CMS
MAYNE PHARMA INC. $25.1502/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959924301 CMS
SERVIER PHARMACEUTICALS LLC $1,760.0002/10/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964202607 CMS
Genentech USA, Inc. $5.2302/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950801667 CMS
Kite Pharma, Inc. $19.1302/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920059827 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,577.96 195
PY2020 $3,534.44 143
PY2021 $6,688.21 263
PY2022 $6,317.83 238
PY2023 $6,656.28 131
PY2024 $3,756.51 102
PY2025 $3,628.91 98

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $651,878.25 7
PY2024 Principal investigator $93,436.60 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $30,805.26 12/23/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF MEVROMETOSTAT PF06821497 WITH ENZALUTAMIDE IN METASTATIC CASTRATIONSENSITIVE PROSTATE CANCER MEVPRO3 No dispute reported 06/30/2026 1228716459
Principal investigator 1 PFIZER INC. $2,286.53 12/18/2025 Non-covered Recipient Entity
Ironwood Physicians PC
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF MEVROMETOSTAT PF06821497 WITH ENZALUTAMIDE IN METASTATIC CASTRATIONSENSITIVE PROSTATE CANCER MEVPRO3 No dispute reported 06/30/2026 1228745060
Principal investigator 1 PFIZER INC. $3,438.41 12/06/2025 Non-covered Recipient Entity
Ironwood Physicians PC
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF MEVROMETOSTAT PF06821497 WITH ENZALUTAMIDE IN METASTATIC CASTRATIONSENSITIVE PROSTATE CANCER MEVPRO3 No dispute reported 06/30/2026 1228745816
Principal investigator 1 PFIZER INC. $30,805.26 11/19/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF MEVROMETOSTAT PF06821497 WITH ENZALUTAMIDE IN METASTATIC CASTRATIONSENSITIVE PROSTATE CANCER MEVPRO3 No dispute reported 06/30/2026 1228716461
Principal investigator 1 PFIZER INC. $46,207.89 10/29/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF MEVROMETOSTAT PF06821497 WITH ENZALUTAMIDE IN METASTATIC CASTRATIONSENSITIVE PROSTATE CANCER MEVPRO3 No dispute reported 06/30/2026 1228716457
Principal investigator 1 PFIZER INC. $23,786.00 10/08/2025 Non-covered Recipient Entity
Ironwood Physicians PC
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF MEVROMETOSTAT PF06821497 WITH ENZALUTAMIDE IN METASTATIC CASTRATIONSENSITIVE PROSTATE CANCER MEVPRO3 No dispute reported 06/30/2026 1228740523
Principal investigator 1 AstraZeneca Pharmaceuticals LP $514,548.90 01/24/2025 Non-covered Recipient Entity
IRONWOOD CANCER AND RESEARCH CENTER CHANDLER I
A Randomized 2-cohort Double-blind Placebo-controlled Phase III Study of AZD5305 in Combination with Physicians Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer EvoPAR-Prostate01 No dispute reported 06/30/2026 1185554775